{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "mesh:D009336",
      "entity_text" : "necrosis",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:53630484",
      "entity_text" : "IPC",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Following this line of reasoning, in vitro and in vivo studies using animal models of CIR showed that treatment with beta-adrenoceptor (beta-AR) agonist isoproterenol (ISO) or ischemic preconditioning (IPC) protocol reduced infarct size, cardiac necrosis and ventricular arrhythmia (VA), reinforcing the concept of sympathetic mechanisms involvement in cardioprotection XREF_BIBR - XREF_BIBR.",
  "reading_complete" : "2020-08-05T18:56:18Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T18:55:11Z",
  "trigger" : "reduced",
  "evidence" : [ "IPC) protocol reduced infarct size, cardiac necrosis" ],
  "pmc_id" : "6583939",
  "score" : 0
}